EHRA 2024: Late-Breaking Science Video Collection

Published: 22 April 2024

  • Views:

    Views Icon 569

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice. 

More from this programme

Part 1

Expert Interviews

7 sessions
Venous Vascular Closure Vs Manual Compression: Style-AF Watch now
FIH Clinical Series of Conformable "Single Shot" PFA Catheter for PVI Watch now
Risk of Stroke or Embolism and AF: ARTESiA Substudy Watch now
Ablation Strategies for Repeat Procedures in Recurrent AF: ASTRO Watch now
Non-Vitamin K Antagonist Oral Anticoagulant in AHRE Patients: NOAH Watch now
Personalised PVI: The QDOT-by-LAWT Trial Watch now
AI-Enabled Single-Lead ECG Can Unmask Conduction Tissue Disease Watch now

Part 2

Highlights

1 session
3 Trials that Will Change My Practice With Dr Luigi Di Biase Watch now

About the episode

EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).

This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.

Interview Questions:

  1. What are the unmet needs in PFA in 2024?
  2. Could you tell us more about the single shot catheter used in this trial?
  3. What was the study design and patient population?
  4. What were the key findings?
  5. What are the next steps?

Recorded on-site at EHRA in Berlin, 2024.

Support: This is an independent interview conducted by Radcliffe Cardiology.

Editors: Jordan Rance, Mirjam Boros

Video Specialist: Oliver Miles

Faculty Biographies

Vivek Reddy

Vivek Reddy

Director of Cardiac Arrhythmia Services

Dr Vivek Y. Reddy is Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and Director of Electrophysiology for the Mount Sinai Health System, and The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai.

Dr Reddy is one of the US's premier cardiac electrophysiologists. He leads a team of physician-scientists who are developing and testing advanced therapies for cardiac arrhythmias and heart failure, including catheter ablation for atrial fibrillation and ventricular tachycardia, and device therapies for stroke prevention. Under his leadership, Mount Sinai is the lead investigational site for many multinational clinical trials exploring new arrhythmia procedures and technologies, most recently pulsed field ablation to treat atrial fibrillation. Moreover, in 2014, he implanted the world’s first miniature leadless pacemaker, as well as the first leadless pacemaker in…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.